On Thursday, an analyst launched coverage of Edgewise Therapeutics (NASDAQ: EWTX) stock, and the market took notice in a good way. On the back of his bullish view of the company, according to data compiled...
Shares of Edgewise Therapeutics EWTX were up more than 18% on Monday after it announced positive results from the mid-stage CANYON study on its lead pipeline drug, sevasemten, in patients with a rare genetic...
Trade the most popular US futures of 2025: Agricultural Commodities, Indices, Crypto, Metals, Forex, and more! Join over 30 million people worldwide who trust Plus500. Start trading today with a deposit as low as $100!
The S&P 500 Index ($SPX ) (SPY ) Monday closed up (+0.38%), the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.45%. Dec E-mini S&P...
The S&P 500 Index ($SPX ) (SPY ) today is up (+0.41%), the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.94%. Dec E-mini S&P futures (ESZ24...
The S&P 500 Index ($SPX ) (SPY ) today is up (+0.31%), the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.76%. Dec E-mini S&P futures (ESZ24...
Stocks had a mostly bullish week as stimulus efforts in the U.S. and China enhanced risk-on sentiment, but next week's jobs report could spark a larger rally
Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?
Edgewise Therapeutics is rocketing higher on positive results for its HCM combating treatment and short-covering. Expect volatility in the weeks ahead.
One of the biopharma company's heart drugs performs as well as initially hoped.